Pharma Journalist -

DirectBiologics, LLC announces the acquisition of Paisley Laboratories, LLC. The mission of these combined research and development companies is to transform regenerative healing with…
Read More...

In the lead up the 3rd Microbiome Movement – Drug Development Europe 2019 in Paris this coming January (28 -30), we’re delighted to announce that Microbiotica, a leading player in…
Read More...

Boehringer Ingelheim and Epizyme announced a new global collaboration focused on the research, development and commercialization of novel small molecule inhibitors directed toward two…
Read More...

Seattle Genetics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to ADCETRIS (brentuximab vedotin) for previously untreated…
Read More...

Mission Therapeutics and AbbVie announced a collaboration in the research and preclinical development of specified DUB inhibitors for the treatment of Alzheimer’s Disease and…
Read More...

AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV)…
Read More...

Nexus Pharmaceuticals announced the immediate availability in the United States for Arsenic Trioxide Injection. Nexus Pharmaceuticals’ Arsenic Trioxide Injection is available as 10mg…
Read More...

Adynxx and twoXAR announced an agreement to develop an oral, non-hormonal drug therapy with the potential to address the underlying mechanisms of endometriosis and significantly improve…
Read More...

Five Prime Therapeutics announced it initiated patient dosing in a Phase 1 clinical trial of FPT155, a first-in-class CD80 fusion protein. The trial was initiated in Australia. “We…
Read More...

Lonza announced the appointment of Allen Burgenson, Global Subject Matter Expert for Endotoxin Detection at Lonza, as Chair of the Horseshoe Crab Advisory Panel of the Atlantic States…
Read More...